Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots in certain heart conditions. Learn about its uses, effects, and precautions.

Aggrastat is primarily used to prevent blood clots in patients undergoing certain heart procedures. It is often administered to reduce the risk of ischemic complications in conditions like unstable angina or during percutaneous coronary interventions. The medication works by inhibiting platelet aggregation, which helps maintain blood flow in critical situations.

Common effects of Aggrastat may include bleeding, bruising, or prolonged bleeding from cuts. Some patients might experience nausea, headache, or dizziness. These effects vary and should be discussed with a healthcare provider.

Aggrastat should be handled with care, especially in patients with a history of bleeding disorders or recent surgery. It is important to monitor for signs of bleeding and to follow medical advice regarding its use. Always inform healthcare providers about any other medications being taken.

Aggrastat may interact with other blood-thinning medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain anticoagulants. Alcohol and other substances that affect blood clotting should be avoided. Consult a healthcare provider for personalized advice.